FIELD: medicine, oncology.
SUBSTANCE: one should carry out morphological testing of therapy results, moreover, in the course of therapy it is necessary to conduct immunohistochemical study for the levels of Ki-67 antigen expression, markers to protein-negative regulator of apoptosis: p53 and Bcl-2 and the level of melanoma marker expression HMB-45 and at decreased levels against the values in untreated tumors it is possible to state upon therapy as efficient. The innovation enables to achieve high clinical efficiency of therapy due to applying neoadjuvant autohemochemotherapy in combination with radiation therapy.
EFFECT: higher accuracy of detection.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ESTIMATING SKIN MELANOMA NEOADJUVANT TREATMENT EFFECTIVENESS | 2006 |
|
RU2322194C1 |
| METHOD FOR DETERMINING AUTOHEMOCHEMOTHERAPY EFFECTIVENESS IN TREATING THE CASES OF CARCINOMA AFFECTING RECTOSIGMOID PORTION OF THE RECTUM AND SIGMOID COLON AND AUTOHEMOCHEMOTHERAPY COMBINED WITH ULTRAHIGH FREQUENCY HYPERTHERMIA IN TREATING THE CASES OF RECTAL CARCINOMA | 2001 |
|
RU2219553C2 |
| METHOD OF EVALUATING EFFICIENCY OF INTRAMURAL AUTOPLASMOCHEMICAL THERAPY OF URINE BLADDER CANCER | 2009 |
|
RU2398517C1 |
| METHOD FOR PREDICTION OF METASTASES IN PATIENTS WITH STOMACH CANCER | 2010 |
|
RU2445632C1 |
| METHOD FOR REMISSION DURATION PREDICTION IN PATIENTS WITH VULVA CANCER | 2016 |
|
RU2624508C1 |
| METHOD OF ESTIMATION OF ANGIOGENIC FACTORS AT CHEMOTHERAPY OF CANCER OF MAMMARY GLAND | 2006 |
|
RU2341198C2 |
| METHOD FOR TREATING UTERINE CHORIOCARCINOMA CASES | 2006 |
|
RU2318502C2 |
| METHOD PREDICTING CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER p53 | 2002 |
|
RU2208789C1 |
| METHOD OF PREDICTION OF CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER Bax | 2002 |
|
RU2208790C1 |
| METHOD FOR TREATING PROSTATIC CANCER | 2004 |
|
RU2258503C1 |
